tiprankstipranks
Resonance Health Ltd (AU:RHT)
:RHT
Australian Market

Resonance Health Ltd (RHT) Price & Analysis

Compare
2 Followers

RHT Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

17.01%82.99%
17.01% Insiders
― Other Institutional Investors
82.99% Public Companies and
Individual Investors

RHT FAQ

What was Resonance Health Ltd’s price range in the past 12 months?
Resonance Health Ltd lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
    What is Resonance Health Ltd’s market cap?
    Resonance Health Ltd’s market cap is AU$22.98M.
      When is Resonance Health Ltd’s upcoming earnings report date?
      Resonance Health Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 178 days.
        How were Resonance Health Ltd’s earnings last quarter?
        Currently, no data Available
        Is Resonance Health Ltd overvalued?
        According to Wall Street analysts Resonance Health Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Resonance Health Ltd pay dividends?
          Resonance Health Ltd does not currently pay dividends.
          What is Resonance Health Ltd’s EPS estimate?
          Resonance Health Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Resonance Health Ltd have?
          Resonance Health Ltd has 459,616,150 shares outstanding.
            What happened to Resonance Health Ltd’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Resonance Health Ltd?
            Currently, no hedge funds are holding shares in AU:RHT
            ---

            Resonance Health Ltd Stock Smart Score

            Company Description

            Resonance Health Ltd

            Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of revenue North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            CardieX Limited
            Biotron Limited
            Imugene Limited
            Somnomed Limited
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis